Trials / Completed
CompletedNCT00913237
To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride 50 mg Tablets
Randomized, 2-way Crossover Bioavailability Study of Desipramine Hydrochloride 50 mg Tablets
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of Desipramine Hydrochloride 50 mg tablets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desipramine Hydrochloride 50 mg Tablets (Cord Laboratories) | |
| DRUG | Desipramine Hydrochloride 50 mg Tablets (Merrell Dow Pharmaceuticals, Inc) |
Timeline
- Start date
- 1987-07-01
- Primary completion
- 1987-08-01
- Completion
- 1987-08-01
- First posted
- 2009-06-04
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00913237. Inclusion in this directory is not an endorsement.